Document is current
Any future updates will be listed below
-
Authors
Gavira, Javier https://orcid.org/0000-0001-6385-3519
Tapia, Jose Carlos
Romano, Alejandra https://orcid.org/0000-0002-0669-4440
Anguera, Georgia https://orcid.org/0000-0002-6060-1110
Aguado, María
Piedra, Aida
Bosma, Freya
Sánchez, Sofía
Martin, Cristina
Algaba, Ferran
Arce, Yolanda
Ramón y Cajal, Teresa
Maroto, Pablo https://orcid.org/0000-0002-0030-0412
- License Information
-
More Information
Article History
Received: 14 January 2024
Accepted: 25 March 2024
First Online: 9 May 2024
Declarations
:
: JG: Speakers’ bureau: Astellas, LEO Pharma. Travel, Accommodation, Expenses: Ipsen, BMS, Novartis, Roche and MSD. JCT: Travel, Accommodations, Expenses: Merck, Pfizer, Roche, MSD and Lily/Genentech. GA participated as Collaborator Investigator in clinical trials using PARPi. Speakers’ Bureau: Astellas Pharma, Ipsen, Bristol Myers Squibb, Merck/Pfizer, Leo pharma. Travel, Accommodations, Expenses: Merck, Ipsen, Bristol Myers Squibb. CM participated as Collaborator Investigator in clinical trials using PARPi. PM: participated as Principal Investigator in clinical trials related to the use of PARPi. Consulting or Advisory Role: Astellas Pharma, Ipsen, BMS, Merck/Pfizer, Bayer, Janssen. Travel, Accommodation, Expenses: Merck/Pfizer, Bayer. The rest of the authors declare no competing financial interest in relation to the work.
